News

As part of ongoing efforts to raise awareness for Esophageal Cancer, a recent educational webinar brought together leading international experts to discuss the evolving landscape of esophageal cancer, with a strong focus on awareness, early detection, multidisciplinary management, and advances in treatment. The session emphasized how collaboration across specialties—and across borders—will be essential to improving outcomes for patients worldwide. 

 Dr. Ania Lipowska of the University of Illinois (United States) opened the program with a presentation on patient awareness, provider education, and epidemiologic trends in esophageal cancer. She highlighted the concerning delays many patients experience before seeking medical attention, often because symptoms such as dysphagia (difficulty swallowing) are not widely recognized by the public as a potential warning sign of cancer. Dr. Lipowska reviewed current screening paradigms and their limitations, particularly their inability to consistently identify younger patients or individuals without chronic gastroesophageal reflux disease (GERD). She called for broader public education campaigns, stronger collaboration with primary care providers, lower referral thresholds for concerning symptoms, and policy initiatives to improve screening access, reimbursement, and healthcare infrastructure.

Dr. Anthony Gamboa of Vanderbilt University Medical Center (United States) then addressed screening, early detection, quality endoscopy, and endoscopic treatment of early malignancy. His presentation focused on Barrett’s esophagus as a key precancerous condition associated with esophageal adenocarcinoma. Dr. Gamboa reviewed current screening approaches, including high-quality endoscopic protocols and emerging non-endoscopic technologies designed to expand access and improve early diagnosis. He also outlined treatment strategies for dysplastic Barrett’s esophagus, including radiofrequency ablation and cryotherapy. For early esophageal cancer, he compared endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), noting that ESD is often preferred for larger or more complex lesions due to its ability to achieve en bloc resection.

The webinar also featured a multidisciplinary discussion on staging and treatment planning for esophageal cancer. Dr. Michael Gibson of Vanderbilt University Medical Center (United States) explained the role of medical oncology in managing locally advanced disease, emphasizing that combining systemic therapy with surgery has significantly improved curative outcomes. The discussion reinforced the importance of coordinated care pathways involving gastroenterology, oncology, radiology, pathology, and surgery to optimize patient management.

Dr. Sabita Jiwnani of Tata Memorial Centre (India) concluded the clinical presentations with an overview of surgical management. She discussed the decision-making process for selecting operative candidates and highlighted the growing benefits of minimally invasive esophagectomy when performed in experienced centers. Her remarks underscored the importance of patient selection, institutional expertise, and multidisciplinary planning in achieving the best surgical outcomes. 

Looking ahead, panelists agreed that the next five years are likely to bring meaningful progress through computer-aided detection systems, non-endoscopic screening tools, and increasingly personalized oncology therapies. These innovations, combined with stronger awareness efforts and integrated care models, have the potential to transform the future of esophageal cancer management worldwide. 

The session concluded with an invitation to continue the conversation at the upcoming ISDE World Congress in Kyoto, Japan.